232414 Motivational Incentives for Enhanced Drug Abuse Recovery

Wednesday, November 10, 2010 : 10:55 AM - 11:20 AM

Maxine Stitzer, PhD , Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD
     
Dr. Stitzer led two CTN clinical trials of low cost incentives, one in methadone centers and one in psychosocial counseling clinics. The studies showed that counseling patients assigned to the abstinence-based incentive condition remained in treatment longer than patients in usual care while methadone maintenance clients assigned to incentives submitted a greater percentage of substance-free urine samples, compared to patients in usual care without incentives. NIDA/SAMHSA adopted the protocol for low-cost incentives into a Blending Product for widespread distribution. Dr. Stitzer and others have continued to spur interest in the best ways to incorporate MI practices into substance abuse treatment, and to refine these approaches to allow more widespread use.

Learning Areas:
Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe the translational research activities of the NIDA Clinical Trials Network, particularly those done in partnership with SAMHSA Discuss Motivational Incentives for treating substance abuse; 1 of the "blending products" developed from research trials sponsored by the NIDA Clinical Trials Network 3. Discuss the NIDA/SAMHSA "fast track" initiative to bring evidence-based treatments into clinical practice more quickly

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I was lead investigator on the CTN multi-site study of Motivational Incentives and have studied and have extensive experience in researching and presenting on this topic.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 5091.0: 25th Anniversary of Alcohol Tobacco & Other Drugs Section and 10th Anniversary of the NIDA Clinical Trials Network: Progress Together